59 related articles for article (PubMed ID: 21543325)
1. The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.
Gerber SS; Lejon S; Locher M; Schaller J
Cell Mol Life Sci; 2010 May; 67(9):1505-18. PubMed ID: 20112045
[TBL] [Abstract][Full Text] [Related]
2. The generation and characterization of mice expressing a plasmin-inactivating active site mutation.
Iwaki T; Malinverno C; Smith D; Xu Z; Liang Z; Ploplis VA; Castellino FJ
J Thromb Haemost; 2010 Oct; 8(10):2341-4. PubMed ID: 20653841
[No Abstract] [Full Text] [Related]
3. Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology.
Kangro K; Campbell RA; Tilvawala R; Flick MJ; Wolberg AS
Res Pract Thromb Haemost; 2023 Aug; 7(6):102195. PubMed ID: 37736033
[No Abstract] [Full Text] [Related]
4. Contactless edema via plasmin.
Strickland S; Norris EH
Blood; 2024 Feb; 143(7):570-571. PubMed ID: 38358851
[No Abstract] [Full Text] [Related]
5. A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen.
Quek AJ; Cowieson NP; Caradoc-Davies TT; Conroy PJ; Whisstock JC; Law RHP
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762561
[TBL] [Abstract][Full Text] [Related]
6. All tangled up: interactions of the fibrinolytic and innate immune systems.
Whyte CS
Front Med (Lausanne); 2023; 10():1212201. PubMed ID: 37332750
[TBL] [Abstract][Full Text] [Related]
7. "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.
Humphreys SJ; Whyte CS; Mutch NJ
Front Cardiovasc Med; 2023; 10():1146833. PubMed ID: 37153474
[TBL] [Abstract][Full Text] [Related]
8. Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.
Alsayejh B; Kietsiriroje N; Almutairi M; Simmons K; Pechlivani N; Ponnambalam S; Ajjan RA
TH Open; 2022 Oct; 6(4):e396-e407. PubMed ID: 36452200
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.
Pechlivani N; Kearney KJ; Ajjan RA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830419
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen Receptors and Fibrinolysis.
Miles LA; Ny L; Wilczynska M; Shen Y; Ny T; Parmer RJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567773
[TBL] [Abstract][Full Text] [Related]
11. Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.
Singh S; Saleem S; Reed GL
Front Cardiovasc Med; 2020; 7():608899. PubMed ID: 33426005
[TBL] [Abstract][Full Text] [Related]
12. α2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline.
Kawashita E; Ishihara K; Miyaji H; Tanishima Y; Kiriyama A; Matsuo O; Akiba S
Mol Brain; 2020 Oct; 13(1):140. PubMed ID: 33059734
[TBL] [Abstract][Full Text] [Related]
13. Functions of the plasminogen receptor Plg-R
Miles LA; Vago JP; Sousa LP; Parmer RJ
J Thromb Haemost; 2020 Oct; 18(10):2468-2481. PubMed ID: 32662180
[TBL] [Abstract][Full Text] [Related]
14. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
15. The Rheumatoid Arthritis-Associated Citrullinome.
Tilvawala R; Nguyen SH; Maurais AJ; Nemmara VV; Nagar M; Salinger AJ; Nagpal S; Weerapana E; Thompson PR
Cell Chem Biol; 2018 Jun; 25(6):691-704.e6. PubMed ID: 29628436
[TBL] [Abstract][Full Text] [Related]
16. Altered behavior in mice with deletion of the alpha2-antiplasmin gene.
Kawashita E; Kanno Y; Ikeda K; Kuretake H; Matsuo O; Matsuno H
PLoS One; 2014; 9(5):e97947. PubMed ID: 24874880
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed serum proteins in infectious purpura fulminans.
He T; Hu JY; Han J; Zhang DX; Jiang XP; Chen B; Huang YS
Dis Markers; 2014; 2014():698383. PubMed ID: 24659849
[TBL] [Abstract][Full Text] [Related]
18. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
Al-Horani RA; Desai UR
Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
[TBL] [Abstract][Full Text] [Related]
19. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]